Takashi Sakuma Selected Research

KW 7158

1/2014

The anti-overactive bladder activity of KW-7158 is mediated by blocking equilibrative nucleoside transporter-1.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Takashi Sakuma Research Topics

Disease

1	Lung Neoplasms (Lung Cancer) 01/2022
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022
1	Cholecystitis 01/2021
1	Hemobilia 01/2021
1	Stomach Neoplasms (Stomach Cancer) 01/2021
1	Adenocarcinoma of Lung 01/2020
1	Neoplasms (Cancer) 01/2020
1	Spinal Cord Injuries (Spinal Cord Injury) 01/2014
1	Overactive Urinary Bladder (Overactive Bladder) 01/2014
1	Subacute Sclerosing Panencephalitis (SSPE) 08/2003
1	Measles 08/2003
1	Hemorrhoids 10/2002

Drug/Important Bio-Agent (IBA)

1	Immune Checkpoint InhibitorsIBA 01/2022
1	Fibrinolytic Agents (Antithrombotic Agents)IBA 01/2021
1	AnticoagulantsIBA 01/2021
1	CrizotinibIBA 01/2020
1	draflazineIBA 01/2014
1	KW 7158IBA 01/2014
1	Dipyridamole (Persantine)FDA LinkGeneric 01/2014
1	NucleosidesIBA 01/2014
1	Ribavirin (Virazole)FDA LinkGeneric 08/2003
1	RNA (Ribonucleic Acid)IBA 08/2003
1	Interferon-alpha (Interferon Alfa)IBA 08/2003

Therapy/Procedure

3	Therapeutics 01/2022 - 08/2003
1	Laparoscopic Cholecystectomy 01/2021
1	Drug Therapy (Chemotherapy) 01/2021
1	Gastrectomy 01/2021
1	Ligation 10/2002